Sign up
Pharma Capital

Bulls, Bears & Brokers: Alto Capital's Tony Locantro talks Bioshares Biotech Summit '18

Stock market commentator and investment manager at Alto Capital Tony Locantro is fresh back from the Bioshares Biotech Summit 2018, held in Queenstown, New Zealand to share all his insights with Proactive Investors.

A range of issues in the health care world were discussed, with gut health and the microbiome being a standout emerging area of interest.

Overall it seems that Australian biotech and pharma companies are relatively undervalued and struggling to raise capital, leaving them exposed to corporate takeovers from overseas players.

Watch our video interview to hear Tony's Bioshares tips.


View full . profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.